Dr. Christine Allen is the Associate Vice-President and Vice-Provost, Strategic Initiatives (AVPVP SI) at the University of Toronto (UofT). She is a full professor in the Leslie Dan Faculty of Pharmacy and holds a PhD in chemistry. Her research focuses on the design of innovative materials and drug delivery technologies. She is the co-founder and served as President of Nanovista Inc., a company focused on high-precision, image-guided cancer therapy. Professor Allen has received career awards from CIHR/Rx&D, the Canadian Society for Pharmaceutical Sciences (CSPS) and the Association of Faculties of Pharmacy of Canada. She is a fellow of the American Institute for Medical and Biological Engineering, CSPS, the Controlled Release Society (CRS) and the Canadian Academy of Health Sciences. She is the Editor-in-Chief of the Journal of Controlled Release, President of CSPS and an appointed member of the Governing Council of the Natural Sciences and Engineering Research Council of Canada. Christine is a strong advocate of equity, diversity and inclusion (EDI) in research and innovation. She is the chair of the inaugural standing committee on EDI in Research and Innovation at UofT, an unconscious bias facilitator and founder of the UofT Women in STEM: Leading and Reading book club.